Our Investors
Artios is backed by top-tier industry investors who share our vision to bring the future of DDR-based medicines to patients with high unmet need cancers.
To date, we have successfully raised $320 million through capital raises and collaborations.
Advancement Through Partnership
We believe in the vast opportunities that DDR-based therapies offer. Strategic partnerships enable us to fully explore these possibilities and maximize the long-term value of our discoveries.
Connect with us to collaborate